Literature DB >> 6192563

Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 2. Effect on colour vision.

J Birch, A M Hamilton.   

Abstract

Patients with long-standing diabetes develop acquired colour vision defects in parallel with retinal vascular changes. This may take the form of an overall loss of hue discrimination or a specific tritan (blue) defect. A battery of colour vision tests can be used to monitor the different features of diabetic retinopathy and to assess the effects of treatment. Diabetic disc new vessels form when approximately a quarter of the retina is ischaemic. The colour vision defect in these patients is usually severe and is frequently tritanopic. The effect of both argon laser and xenon arc panretinal photocoagulation is to increase the severity of the colour defect. All the eyes examined were tritanopic after treatment and did not recover during the 12-month follow-up period. The severity of this acquired colour vision defect can result in practical difficulties for the patient.

Entities:  

Mesh:

Year:  1981        PMID: 6192563

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  6 in total

1.  Panretinal laser photocoagulation for proliferative diabetic retinopathy: the effect of laser wavelength on macular function.

Authors:  C Canning; P Polkinghorne; A Ariffin; Z Gregor
Journal:  Br J Ophthalmol       Date:  1991-10       Impact factor: 4.638

2.  A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.

Authors:  A P Plumb; A V Swan; A H Chignell; J S Shilling
Journal:  Br J Ophthalmol       Date:  1982-04       Impact factor: 4.638

Review 3.  Diabetic retinopathy (treatment).

Authors:  Quresh Amir Mohamed; Adam Ross; Colin Jonathan Chu
Journal:  BMJ Clin Evid       Date:  2011-05-25

4.  Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.

Authors:  Grace E Boynton; Maxwell S Stem; Leon Kwark; Gregory R Jackson; Sina Farsiu; Thomas W Gardner
Journal:  Ophthalmology       Date:  2015-01-17       Impact factor: 12.079

Review 5.  Diabetic retinopathy.

Authors:  Efstratios Mendrinos; Alexandros N Stangos; Constantin J Pournaras
Journal:  BMJ Clin Evid       Date:  2007-11-23

6.  Short-term effect of slit-lamp illumination and argon laser light on visual function of diabetic and non-diabetic subjects.

Authors:  I M Ghafour; W S Foulds; D Allan
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.